A Trusted Source of Intelligent Data

  • Solutions
    • Subscription Model *NEW*
    • Healthcare Market Reports
    • MedSKU Brand Analysis
    • Procedure Tracker
    • Medical Market Surveys
    • Total Sales Solution
    • Custom Consulting
    • iData Pharma
    • iData Online
  • Reports
  • Platforms
  • News
    • MedTech Future
    • CardioFuture
    • DentalFuture
    • OrthoFuture
    • COVID-19
    • Press Releases
  • About Us
    • About Us
    • Do it Right
    • Research Methodology
    • Careers
    • Testimonials
    • FAQs
  • Contact Us
  • Serach
  • Login
Login
  • Home
  • Telemedicine in Diabetes Care: Is It the Future?
Search for:

Category: Diabetes

Telemedicine in Diabetes Care: Is It the Future?

Telemedicine in Diabetes Care: Is It the Future?

08/05/2025 Maksym Brylkov
Telemedicine in diabetes care is rapidly transforming how patients manage chronic conditions like Type 1 and Type 2 diabetes. From continuous glucose monitoring (CGM) to app-based coaching and virtual... Read More
U.S. Diabetes Market Size And Growth: What Investors Need to Know in 2025

U.S. Diabetes Market Size And Growth: What Investors Need to Know in 2025

17/04/2025 Maksym Brylkov
The U.S. diabetes market is undergoing a rapid transformation, fueled by technological innovation, rising obesity rates, and growing demand for smarter, more personalized treatment options. Valued at ... Read More
Non-Injectable Diabetes Medications and Treatments in 2025

Non-Injectable Diabetes Medications and Treatments in 2025

20/03/2025 Maksym Brylkov
For decades, injectable insulin and GLP-1 receptor agonists have been the gold standard in diabetes management. But for millions of patients, daily injections are painful, inconvenient, and often lead... Read More
The Ultimate US Diabetes Market Overview in 2025: Trends, Innovations, and Market Growth

The Ultimate US Diabetes Market Overview in 2025: Trends, Innovations, and Market Growth

11/03/2025 Maksym Brylkov
The Ultimate US Diabetes Market Overview explores the current state of the US diabetes market in the year 2025, breaking down key industry trends, major players, and technological innovations that are... Read More
Top 5 Diabetes Drugs in 2025

Top 5 Diabetes Drugs in 2025

26/02/2025 Maksym Brylkov
Diabetes treatment is evolving rapidly, with pharmaceutical companies racing to develop more effective therapies. The combined cost of diagnosed diabetes and prediabetes in the United States amounts t... Read More
Flash Glucose Monitoring Continues to Grow Despite the Presence of CGM Industry

Flash Glucose Monitoring Continues to Grow Despite the Presence of CGM Industry

13/02/2025 Andrew Sung
The continuous glucose monitoring (CGM) market has experienced strong but slowing growth in the U.S. blood glucose monitoring sector. Valued at over $6 billion in 2024, the market is only projected to... Read More
Ozempic FDA-Approved to Lower Kidney Disease Risk in Diabetic Patients

Ozempic FDA-Approved to Lower Kidney Disease Risk in Diabetic Patients

06/02/2025 Andrew Sung
Earlier last week, the US Food and Drug Administration (FDA) approved Novo Nordisk to utilize their already successful semaglutide drug, Ozempic, to reduce the risk of kidney failure and kidney diseas... Read More
Top 4 Continuous Glucose Monitoring Companies in the U.S.

Top 4 Continuous Glucose Monitoring Companies in the U.S.

05/07/2021 Emma Matrick
Within the glucose monitoring market, continuous glucose monitoring (CGM) is a way for patients to continually measure their glucose levels in different settings. Four companies compete to gain a domi... Read More
New Diabetes Test Using Smartphone and Deep Learning

New Diabetes Test Using Smartphone and Deep Learning

27/08/2020 iData Research
Researchers at UCSF have developed a method to help detect diabetes using a smartphone. They have developed a deep-learning technology that can be combined with a mobile app to offer a low-cost method... Read More
Abbott Granted FDA Approval for Freestyle Libre 2 Glucose Monitor

Abbott Granted FDA Approval for Freestyle Libre 2 Glucose Monitor

07/07/2020 iData Research
The most recent integrated continuous glucose monitor (iCGM) from Abbott, the Freestyle Libre 2, has been granted FDA approval for sale in the U.S. to adults and children over the age of four with dia... Read More
  • 1 of 3
  • 1
  • 2
  • 3
  • Next »

    Want more information about the market report mentioned in this article?

    Free Sample Report
    Subscribe to iData News

    We publish medical, dental, and pharmaceutical news and market insights from our analysts every day. Sign up for your free subscription here:

    Subscribe
+

Free Sample Report

    [create_popup_free_sample_report_rorm_v6]

    Subscribe to our Newsletter
    Subscribe

    OUR ADDRESS

    • 602-7300 Edmonds St, Kings Crossing, Burnaby, BC V3N 0G8, Canada
    • +1 (604) 266-6933
    • +1 (866) 964-3282
    • 8 The Green #21910, Dover, DE, 19901, United States
    • +1 (302) 579-0728
    • info@idataresearch.net

    SOLUTIONS

    • Report
    • Custom Consulting
    • MedSKU Brand Analysis
    • Procedure Tracker
    • Surveys
    • Total Sales Solution
    • Pharmaceuticals
    • iDataOnline

    NEWS

    • Blog
    • MedTech Future
    • Cardio Future
    • Dental Future
    • Ortho Future
    • Subscribe

    ABOUT US

    • About iData
    • Our Methodology
    • Testimonials
    • FAQ
    • Careers

    OTHER

    • Terms of Use
    • Privacy Policy
    • Sitemap

    Copyright © 2005 - 2025 iData Research. All Rights Reserved

    0
      0
      Your Cart
      Your cart is emptyReturn to Report Library